Atlas Capital Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$275K Sell
3,940
-300
-7% -$21K 0.03% 348
2025
Q1
$312K Buy
4,240
+142
+3% +$10.4K 0.04% 330
2024
Q4
$269K Sell
4,098
-1,411
-26% -$92.4K 0.03% 341
2024
Q3
$429K Buy
5,509
+300
+6% +$23.4K 0.07% 253
2024
Q2
$406K Sell
5,209
-497
-9% -$38.8K 0.05% 266
2024
Q1
$387K Sell
5,706
-2,687
-32% -$182K 0.06% 262
2023
Q4
$565K Sell
8,393
-545
-6% -$36.7K 0.08% 199
2023
Q3
$605K Sell
8,938
-267
-3% -$18.1K 0.1% 161
2023
Q2
$659K Sell
9,205
-131
-1% -$9.38K 0.1% 153
2023
Q1
$648K Hold
9,336
0.1% 150
2022
Q4
$633K Sell
9,336
-3,908
-30% -$265K 0.11% 158
2022
Q3
$726K Hold
13,244
0.13% 127
2022
Q2
$875K Hold
13,244
0.15% 113
2022
Q1
$879K Buy
13,244
+255
+2% +$16.9K 0.14% 133
2021
Q4
$757K Buy
12,989
+424
+3% +$24.7K 0.11% 153
2021
Q3
$755K Buy
12,565
+874
+7% +$52.5K 0.12% 138
2021
Q2
$700K Hold
11,691
0.12% 162
2021
Q1
$581K Sell
11,691
-575
-5% -$28.6K 0.11% 174
2020
Q4
$613K Sell
12,266
-2,284
-16% -$114K 0.13% 153
2020
Q3
$797K Sell
14,550
-1,312
-8% -$71.9K 0.19% 122
2020
Q2
$839K Sell
15,862
-515
-3% -$27.2K 0.2% 113
2020
Q1
$731K Sell
16,377
-410
-2% -$18.3K 0.22% 111
2019
Q4
$837K Sell
16,787
-4,652
-22% -$232K 0.21% 124
2019
Q3
$956K Buy
21,439
+655
+3% +$29.2K 0.29% 99
2019
Q2
$858K Buy
20,784
+561
+3% +$23.2K 0.28% 99
2019
Q1
$818K Hold
20,223
0.3% 96
2018
Q4
$768K Sell
20,223
-7,638
-27% -$290K 0.31% 88
2018
Q3
$1.12M Sell
27,861
-6,568
-19% -$263K 0.37% 75
2018
Q2
$1.28M Buy
+34,429
New +$1.28M 0.45% 56